Search research articles
Contact Us
Filters
Showing results (551-560 of 1,163) with videos related to
Page
of 117
Sort By:
The New England Journal of Medicine
|
July 2, 2021
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
Hertzel C Gerstein, Naveed Sattar, Julio Rosenstock, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 15, 2021
New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial
João Pedro Ferreira, John G Cleland, Carolyn S P Lam, et al.
The American Journal of Cardiology
|
October 2, 2018
Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction
Andrew P Ambrosy, Hillary Mulder, Adrian Coles, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 27, 2013
Asbestos-induced alveolar epithelial cell apoptosis. The role of endoplasmic reticulum stress response
David W Kamp, Gang Liu, Paul Cheresh, et al.
Clinical Chemistry and Laboratory Medicine
|
October 7, 2018
Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB)
Amy K Saenger, Allan S Jaffe, Richard Body, et al.
Journal of the American College of Cardiology
|
March 16, 2018
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study
Mikhail Kosiborod, Carolyn S P Lam, Shun Kohsaka, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2026
Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O Trial
Daniel Raaschou-Oddershede, Christine R Schwarz, Tanya Kovalova, et al.
Journal of Cardiac Failure
|
March 1, 2021
Generalizability of HFA-PEFF and H<sub>2</sub>FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF
U L Faxen, Ashwin Venkateshvaran, Sanjiv J Shah, et al.
Scientific Reports
|
May 20, 2022
Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction
Nicolas Girerd, John Cleland, Stefan D Anker, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 11, 2019
IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma
Siao Ting Chong, Khee Ming Tan, Catherine Y L Kok, et al.
Page
of 117
Search research articles
Search
Showing results (551-560 of 1,163) with videos related to
Sort By:
Page
of 117
The New England Journal of Medicine
|
July 2, 2021
Cardiovascular and Renal Outcomes with Efpeglenatide in Type 2 Diabetes
Hertzel C Gerstein, Naveed Sattar, Julio Rosenstock, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society
|
June 15, 2021
New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial
João Pedro Ferreira, John G Cleland, Carolyn S P Lam, et al.
The American Journal of Cardiology
|
October 2, 2018
Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction
Andrew P Ambrosy, Hillary Mulder, Adrian Coles, et al.
American Journal of Respiratory Cell and Molecular Biology
|
July 27, 2013
Asbestos-induced alveolar epithelial cell apoptosis. The role of endoplasmic reticulum stress response
David W Kamp, Gang Liu, Paul Cheresh, et al.
Clinical Chemistry and Laboratory Medicine
|
October 7, 2018
Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB)
Amy K Saenger, Allan S Jaffe, Richard Body, et al.
Journal of the American College of Cardiology
|
March 16, 2018
Cardiovascular Events Associated With SGLT-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL 2 Study
Mikhail Kosiborod, Carolyn S P Lam, Shun Kohsaka, et al.
Diabetes, Obesity & Metabolism
|
July 2, 2026
Potential Mediators of Efpeglenatide's Cardiovascular Benefit: An Exploratory Analysis of the AMPLITUDE-O Trial
Daniel Raaschou-Oddershede, Christine R Schwarz, Tanya Kovalova, et al.
Journal of Cardiac Failure
|
March 1, 2021
Generalizability of HFA-PEFF and H<sub>2</sub>FPEF Diagnostic Algorithms and Associations With Heart Failure Indices and Proteomic Biomarkers: Insights From PROMIS-HFpEF
U L Faxen, Ashwin Venkateshvaran, Sanjiv J Shah, et al.
Scientific Reports
|
May 20, 2022
Inflammation and remodeling pathways and risk of cardiovascular events in patients with ischemic heart failure and reduced ejection fraction
Nicolas Girerd, John Cleland, Stefan D Anker, et al.
The Journal of Clinical Endocrinology and Metabolism
|
July 11, 2019
IL13RA2 Is Differentially Regulated in Papillary Thyroid Carcinoma vs Follicular Thyroid Carcinoma
Siao Ting Chong, Khee Ming Tan, Catherine Y L Kok, et al.
Page
of 117